The groundbreaking rise of Viagra has long been a example of pharmaceutical success, but its legacy within the broader sector now triggers questions about long-term returns . Copycat versions are eroding market share, leading to concerns that investing in companies closely tied to Viagra's former influence could be a speculative strategy, especi… Read More